Photodynamic therapy and anti-tumour immunity (original) (raw)

• Moan, J. & Peng, Q. An outline of the hundred-year history of PDT. Anticancer Res. 23, 3591–3600 (2003).
  PubMed Google Scholar
• Dolmans, D. E., Fukumura, D. & Jain, R. K. Photodynamic therapy for cancer. Nature Rev. Cancer 3, 380–387 (2003). A recent review on the theory and applications of PDT in cancer treatment.
  Article CAS Google Scholar
• Detty, M. R., Gibson, S. L. & Wagner, S. J. Current clinical and preclinical photosensitizers for use in photodynamic therapy. J. Med. Chem. 47, 3897–3915 (2004).
  Article CAS PubMed Google Scholar
• Castano, A. P., Demidova, T. N. & Hamblin, M. R. Mechanisms in photodynamic therapy: part two — cellular signalling, cell metabolism and modes of cell death. Photodiagn. Photodyn. Ther. 2, 1–23 (2005).
  Article CAS Google Scholar
• Castano, A. P., Demidova, T. N. & Hamblin, M. R. Mechanisms in photodynamic therapy: part three-photosensitizer pharmacokinetics, biodistribution, tumor localization and modes of tumor destruction. Photodiagn. Photodyn. Ther. 2, 91–106 (2005).
  Article CAS Google Scholar
• Oleinick, N. L., Morris, R. L. & Belichenko, I. The role of apoptosis in response to photodynamic therapy: what, where, why, and how. Photochem. Photobiol. Sci. 1, 1–21 (2002).
  Article CAS PubMed Google Scholar
• Krammer, B. Vascular effects of photodynamic therapy. Anticancer Res. 21, 4271–4277 (2001).
  CAS PubMed Google Scholar
• Dolmans, D. E. et al. Vascular accumulation of a novel photosensitizer, MV6401, causes selective thrombosis in tumor vessels after photodynamic therapy. Cancer Res. 62, 2151–2156 (2002).
  CAS PubMed Google Scholar
• Korbelik, M. Induction of tumor immunity by photodynamic therapy. J. Clin. Laser Med. Surg. 14, 329–334 (1996).
  Article CAS PubMed Google Scholar
• van Duijnhoven, F. H. et al. The immunological consequences of photodynamic treatment of cancer, a literature review. Immunobiology 207, 105–113 (2003).
  Article CAS PubMed Google Scholar
• Canti, G., De Simone, A. & Korbelik, M. Photodynamic therapy and the immune system in experimental oncology. Photochem. Photobiol. Sci. 1, 79–80 (2002).
  Article CAS PubMed Google Scholar
• Lugade, A. A. et al. Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor. J. Immunol. 174, 7516–7523 (2005).
  Article CAS PubMed Google Scholar
• Friedman, E. J. Immune modulation by ionizing radiation and its implications for cancer immunotherapy. Curr. Pharm. Des. 8, 1765–1780 (2002).
  Article CAS PubMed Google Scholar
• Crum, E. D. Effect of cisplatin upon expression of in vivo immune tumor resistance. Cancer Immunol. Immunother. 36, 18–24 (1993).
  Article CAS PubMed Google Scholar
• Sierra-Rivera, E., Voorhees, G. J. & Freeman, M. L. g irradiation increases hsp-70 in Chinese hamster ovary cells. Radiat. Res. 135, 40–45 (1993).
  Article CAS PubMed Google Scholar
• Ng, C. S. et al. Thoracotomy is associated with significantly more profound suppression in lymphocytes and natural killer cells than video-assisted thoracic surgery following major lung resections for cancer. J. Invest. Surg. 18, 81–88 (2005).
  Article PubMed Google Scholar
• Fontana, G. et al. Immunological response to prostatic cancer cryotherapy: certainties, controversies, hypotheses. Prog. Clin. Biol. Res. 303, 299–300 (1989).
  CAS PubMed Google Scholar
• Ivarsson, K. et al. Resistance to tumour challenge after tumour laser thermotherapy is associated with a cellular immune response. Br. J. Cancer 93, 435–440 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Challis, G. B. & Stam, H. J. The spontaneous regression of cancer. A review of cases from 1900 to 1987. Acta Oncol. 29, 545–550 (1990). A collection of 744 cases of spontaneous regressions of cancer in humans, showing the theoretical justification for immunotherapy.
  Article CAS PubMed Google Scholar
• Hoption Cann, S. A., van Netten, J. P. & van Netten, C. Dr William Coley and tumour regression: a place in history or in the future. Postgrad. Med. J. 79, 672–680 (2003).
  CAS PubMed PubMed Central Google Scholar
• Starnes, C. O. Coley's toxins in perspective. Nature 357, 11–12 (1992).
  Article CAS PubMed Google Scholar
• Coley, W. B. Treatment of inoperable malignant tumors with toxins of erysipelas and the bacillus prodigiosus. Trans. Am. Surg. Assn. 12, 183–212 (1894).
  Google Scholar
• Bassi, P. BCG (Bacillus of Calmette Guerin) therapy of high-risk superficial bladder cancer. Surg. Oncol. 11, 77–83 (2002).
  Article PubMed Google Scholar
• Zinkernagel, R. M. & Doherty, P. C. MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness. Adv. Immunol. 27, 51–177 (1979).
  Article CAS PubMed Google Scholar
• Banchereau, J. & Steinman, R. M. Dendritic cells and the control of immunity. Nature 392, 245–252 (1998).
  Article CAS PubMed Google Scholar
• Belardelli, F. & Ferrantini, M. Cytokines as a link between innate and adaptive antitumor immunity. Trends Immunol. 23, 201–208 (2002).
  Article CAS PubMed Google Scholar
• Kern, D. E., Klarnet, J. P., Jensen, M. C. & Greenberg, P. D. Requirement for recognition of class II molecules and processed tumor antigen for optimal generation of syngeneic tumor-specific class I-restricted CTL. J. Immunol. 136, 4303–4310 (1986).
  CAS PubMed Google Scholar
• Ahmad, M., Rees, R. C. & Ali, S. A. Escape from immunotherapy: possible mechanisms that influence tumor regression/progression. Cancer Immunol. Immunother. 53, 844–854 (2004).
  Article PubMed Google Scholar
• Zou, W. Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nature Rev. Cancer 5, 263–274 (2005).
  Article CAS Google Scholar
• Agostinis, P., Buytaert, E., Breyssens, H. & Hendrickx, N. Regulatory pathways in photodynamic therapy induced apoptosis. Photochem. Photobiol. Sci. 3, 721–729 (2004).
  Article CAS PubMed Google Scholar
• Moor, A. C. Signaling pathways in cell death and survival after photodynamic therapy. J. Photochem. Photobiol. B 57, 1–13 (2000).
  Article CAS PubMed Google Scholar
• Plaetzer, K., Kiesslich, T., Oberdanner, C. B. & Krammer, B. Apoptosis following photodynamic tumor therapy: induction, mechanisms and detection. Curr. Pharm. Des 11, 1151–1165 (2005).
  Article CAS PubMed Google Scholar
• Chen, B. et al. Photodynamic therapy with hypericin induces vascular damage and apoptosis in the RIF-1 mouse tumor model. Int. J. Cancer 98, 284–290 (2002).
  Article CAS PubMed Google Scholar
• Kaneko, T., Chiba, H., Yasuda, T. & Kusama, K. Detection of photodynamic therapy-induced early apoptosis in human salivary gland tumor cells in vitro and in a mouse tumor model. Oral Oncol. 40, 787–792 (2004).
  Article CAS PubMed Google Scholar
• Lilge, L., Portnoy, M. & Wilson, B. C. Apoptosis induced in vivo by photodynamic therapy in normal brain and intracranial tumour tissue. Br. J. Cancer 83, 1110–1117 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Magner, W. J. & Tomasi, T. B. Apoptotic and necrotic cells induced by different agents vary in their expression of MHC and costimulatory genes. Mol. Immunol. 42, 1033–1042 (2005).
  Article CAS PubMed Google Scholar
• Bartholomae, W. C. et al. T cell immunity induced by live, necrotic, and apoptotic tumor cells. J. Immunol. 173, 1012–1022 (2004).
  Article CAS PubMed Google Scholar
• Scheffer, S. R. et al. Apoptotic, but not necrotic, tumor cell vaccines induce a potent immune response in vivo. Int. J. Cancer 103, 205–211 (2003).
  Article CAS PubMed Google Scholar
• Shaif-Muthana, M. et al. Dead or alive: immunogenicity of human melanoma cells when presented by dendritic cells. Cancer Res. 60, 6441–6447 (2000).
  CAS PubMed Google Scholar
• Zitvogel, L. et al. Immune response against dying tumor cells. Adv. Immunol. 84, 131–179 (2004).
  Article CAS PubMed Google Scholar
• Melcher, A., Gough, M., Todryk, S. & Vile, R. Apoptosis or necrosis for tumor immunotherapy: what's in a name? J. Mol. Med. 77, 824–833 (1999).
  Article CAS PubMed Google Scholar
• Yenari, M. A. et al. Antiapoptotic and anti-inflammatory mechanisms of heat-shock protein protection. Ann. NY Acad. Sci. 1053, 74–83 (2005).
  Article CAS PubMed Google Scholar
• Korbelik, M., Sun, J. & Cecic, I. Photodynamic therapy-induced cell surface expression and release of heat shock proteins: relevance for tumor response. Cancer Res. 65, 1018–1026 (2005).
  CAS PubMed Google Scholar
• Todryk, S. et al. Heat shock protein 70 induced during tumor cell killing induces Th1 cytokines and targets immature dendritic cell precursors to enhance antigen uptake. J. Immunol. 163, 1398–1408 (1999).
  CAS PubMed Google Scholar
• Gomer, C. J. et al. Photodynamic therapy-mediated oxidative stress can induce expression of heat shock proteins. Cancer Res. 56, 2355–2360 (1996). Demonstrates that PDT induces HSP expression both in vitro and in vivo.
  CAS PubMed Google Scholar
• Mitra, S., Goren, E. M., Frelinger, J. G. & Foster, T. H. Activation of heat shock protein 70 promoter with meso-tetrahydroxyphenyl chlorin photodynamic therapy reported by green fluorescent protein in vitro and in vivo. Photochem. Photobiol. 78, 615–622 (2003).
  Article CAS PubMed Google Scholar
• Verwanger, T. et al. Gene expression pattern following photodynamic treatment of the carcinoma cell line A-431 analysed by cDNA arrays. Int. J. Oncol. 21, 1353–1359 (2002).
  CAS PubMed Google Scholar
• Verrico, A. K., Haylett, A. K. & Moore, J. V. In vivo expression of the collagen-related heat shock protein HSP47, following hyperthermia or photodynamic therapy. Lasers Med. Sci. 16, 192–198 (2001).
  Article CAS PubMed Google Scholar
• Hanlon, J. G. et al. Induction of Hsp60 by Photofrin-mediated photodynamic therapy. J. Photochem. Photobiol. B 64, 55–61 (2001).
  Article CAS PubMed Google Scholar
• Gomer, C. J. et al. Glucose regulated protein induction and cellular resistance to oxidative stress mediated by porphyrin photosensitization. Cancer Res. 51, 6574–6579 (1991).
  CAS PubMed Google Scholar
• Nowis, D. et al. Heme oxygenase-1 protects tumor cells against photodynamic therapy-mediated cytotoxicity. Oncogene 6 Feb 2006 (doi 10. 1038/sj. onc1209378).
• Jiang, H. et al. Selective depletion of a thymocyte subset in vitro with an immunomodulatory photosensitizer. Clin. Immunol. 91, 178–187 (1999).
  Article CAS PubMed Google Scholar
• Jiang, H. et al. Selective action of the photosensitizer QLT0074 on activated human T lymphocytes. Photochem. Photobiol. 76, 224–231 (2002).
  Article CAS PubMed Google Scholar
• Boumedine, R. S. & Roy, D. C. Elimination of alloreactive T cells using photodynamic therapy. Cytotherapy 7, 134–143 (2005).
  Article CAS PubMed Google Scholar
• Hunt, D. W. & Levy, J. G. Immunomodulatory aspects of photodynamic therapy. Expert Opin. Investig. Drugs 7, 57–64 (1998).
  Article CAS PubMed Google Scholar
• Edstrom, D. W., Porwit, A. & Ros, A. M. Photodynamic therapy with topical 5-aminolevulinic acid for mycosis fungoides: clinical and histological response. Acta Derm. Venereol. 81, 184–188 (2001).
  Article CAS PubMed Google Scholar
• Steubing, R. W. et al. Activation of macrophages by Photofrin II during photodynamic therapy. J. Photochem. Photobiol. B 10, 133–145 (1991).
  Article CAS PubMed Google Scholar
• Evans, S. et al. Effect of photodynamic therapy on tumor necrosis factor production by murine macrophages. J. Natl Cancer Inst. 82, 34–39 (1990). Shows that PDT produces TNF α from macrophages.
  Article CAS PubMed Google Scholar
• Yamamoto, N. et al. Photodynamic immunopotentiation: in vitro activation of macrophages by treatment of mouse peritoneal cells with haematoporphyrin derivative and light. Eur. J. Cancer 27, 467–471 (1991).
  Article CAS PubMed Google Scholar
• Yamamoto, N. & Naraparaju, V. R. Immunotherapy of BALB/c mice bearing Ehrlich ascites tumor with vitamin D-binding protein-derived macrophage activating factor. Cancer Res. 57, 2187–2192 (1997).
  CAS PubMed Google Scholar
• Korbelik, M. & Krosl, G. Enhanced macrophage cytotoxicity against tumor cells treated with photodynamic therapy. Photochem. Photobiol. 60, 497–502 (1994).
  Article CAS PubMed Google Scholar
• Marshall, J. F., Chan, W. S. & Hart, I. R. Effect of photodynamic therapy on anti-tumor immune defenses: comparison of the photosensitizers hematoporphyrin derivative and chloro-aluminum sulfonated phthalocyanine. Photochem. Photobiol. 49, 627–632 (1989).
  Article CAS PubMed Google Scholar
• Gollnick, S. O. et al. Role of cytokines in photodynamic therapy-induced local and systemic inflammation. Br. J. Cancer 88, 1772–1779 (2003). Describes the production of pro-inflammatory cytokines after PDT in vivo.
  Article CAS PubMed PubMed Central Google Scholar
• Yom, S. S. et al. Elevated serum cytokine levels in mesothelioma patients who have undergone pleurectomy or extrapleural pneumonectomy and adjuvant intraoperative photodynamic therapy. Photochem. Photobiol. 78, 75–81 (2003).
  Article CAS PubMed Google Scholar
• Henderson, B. W. & Donovan, J. M. Release of prostaglandin E2 from cells by photodynamic treatment in vitro. Cancer Res. 49, 6896–6900 (1989).
  CAS PubMed Google Scholar
• Henderson, B. W., Owczarczak, B., Sweeney, J. & Gessner, T. Effects of photodynamic treatment of platelets or endothelial cells in vitro on platelet aggregation. Photochem. Photobiol. 56, 513–521 (1992).
  Article CAS PubMed Google Scholar
• Fingar, V. H., Wieman, T. J. & Doak, K. W. Role of thromboxane and prostacyclin release on photodynamic therapy-induced tumor destruction. Cancer Res. 50, 2599–2603 (1990).
  CAS PubMed Google Scholar
• Balkwill, F., Charles, K. A. & Mantovani, A. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 7, 211–217 (2005).
  Article CAS PubMed Google Scholar
• Sun, S. C. & Xiao, G. Deregulation of NF-κB and its upstream kinases in cancer. Cancer Metastasis Rev. 22, 405–422 (2003).
  Article CAS PubMed Google Scholar
• Baeuerle, P. A. & Henkel, T. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12, 141–179 (1994).
  Article CAS PubMed Google Scholar
• Haefner, B. NF-κB: arresting a major culprit in cancer. Drug Discov. Today 7, 653–663 (2002).
  Article CAS PubMed Google Scholar
• Ryter, S. W. & Gomer, C. J. Nuclear factor κB binding activity in mouse L1210 cells following photofrin II-mediated photosensitization. Photochem. Photobiol. 58, 753–756 (1993). First report of PDT triggering NFκB signalling.
  Article CAS PubMed Google Scholar
• Kick, G. et al. Photodynamic therapy induces expression of interleukin 6 by activation of AP-1 but not NF-κB DNA binding. Cancer Res. 55, 2373–2379 (1995).
  CAS PubMed Google Scholar
• Matroule, J. Y. et al. Pyropheophorbide-a methyl ester-mediated photosensitization activates transcription factor NF-κB through the interleukin-1 receptor-dependent signaling pathway. J. Biol. Chem. 274, 2988–3000 (1999).
  Article CAS PubMed Google Scholar
• Matroule, J. Y. et al. Role of nuclear factor-κB in colon cancer cell apoptosis mediated by aminopyropheophorbide photosensitization. Photochem. Photobiol. 70, 540–548 (1999).
  CAS PubMed Google Scholar
• Granville, D. J. et al. Nuclear factor-κB activation by the photochemotherapeutic agent verteporfin. Blood 95, 256–262 (2000).
  CAS PubMed Google Scholar
• Ferrario, A. et al. Cyclooxygenase-2 inhibitor treatment enhances photodynamic therapy- mediated tumor response. Cancer Res. 62, 3956–3961 (2002).
  CAS PubMed Google Scholar
• Mitsuhashi, M. et al. Regulation of interleukin-12 gene expression and its anti-tumor activities by prostaglandin E2 derived from mammary carcinomas. J. Leukoc. Biol. 76, 322–332 (2004).
  Article CAS PubMed Google Scholar
• Makowski, M. et al. Inhibition of cyclooxygenase-2 indirectly potentiates antitumor effects of photodynamic therapy in mice. Clin. Cancer Res. 9, 5417–5422 (2003).
  CAS PubMed Google Scholar
• Volanti, C. et al. Distinct transduction mechanisms of cyclooxygenase 2 gene activation in tumour cells after photodynamic therapy. Oncogene 24, 2981–2991 (2005).
  Article CAS PubMed Google Scholar
• Hendrickx, N. et al. Up-regulation of cyclooxygenase-2 and apoptosis resistance by p38 MAPK in hypericin-mediated photodynamic therapy of human cancer cells. J. Biol. Chem. 278, 52231–52239 (2003).
  Article CAS PubMed Google Scholar
• Gollnick, S. O. et al. Altered expression of interleukin 6 and interleukin 10 as a result of photodynamic therapy in vivo. Cancer Res. 57, 3904–3909 (1997).
  CAS PubMed Google Scholar
• Henderson, B. W. et al. Choice of oxygen-conserving treatment regimen determines the inflammatory response and outcome of photodynamic therapy of tumors. Cancer Res. 64, 2120–2126 (2004).
  Article CAS PubMed Google Scholar
• Coutier, S. et al. Effect of irradiation fluence rate on the efficacy of photodynamic therapy and tumor oxygenation in meta-tetra (hydroxyphenyl) chlorin (mTHPC)-sensitized HT29 xenografts in nude mice. Radiat. Res. 158, 339–345 (2002).
  Article CAS PubMed Google Scholar
• Sluiter, W., de Vree, W. J., Pietersma, A. & Koster, J. F. Prevention of late lumen loss after coronary angioplasty by photodynamic therapy: role of activated neutrophils. Mol. Cell. Biochem. 157, 233–238 (1996).
  Article CAS PubMed Google Scholar
• de Vree, W. J., Fontijne-Dorsman, A. N., Koster, J. F. & Sluiter, W. Photodynamic treatment of human endothelial cells promotes the adherence of neutrophils in vitro. Br. J. Cancer 73, 1335–1340 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Volanti, C. et al. Downregulation of ICAM-1 and VCAM-1 expression in endothelial cells treated by photodynamic therapy. Oncogene 23, 8649–8658 (2004).
  Article CAS PubMed Google Scholar
• de Vree, W. J. et al. Evidence for an important role of neutrophils in the efficacy of photodynamic therapy in vivo. Cancer Res. 56, 2908–2911 (1996). Shows that neutrophils have a crucial role in the PDT response in vivo.
  CAS PubMed Google Scholar
• Krosl, G., Korbelik, M. & Dougherty, G. J. Induction of immune cell infiltration into murine SCCVII tumour by photofrin-based photodynamic therapy. Br. J. Cancer 71, 549–555 (1995).
  Article CAS PubMed PubMed Central Google Scholar
• Cecic, I., Parkins, C. S. & Korbelik, M. Induction of systemic neutrophil response in mice by photodynamic therapy of solid tumors. Photochem. Photobiol. 74, 712–720 (2001).
  Article CAS PubMed Google Scholar
• Kajita, T. & Hugli, T. E. C5a-induced neutrophilia. A primary humoral mechanism for recruitment of neutrophils. Am. J. Pathol. 137, 467–477 (1990).
  CAS PubMed PubMed Central Google Scholar
• Cecic, I., Serrano, K., Gyongyossy-Issa, M. & Korbelik, M. Characteristics of complement activation in mice bearing Lewis lung carcinomas treated by photodynamic therapy. Cancer Lett. 225, 215–223 (2005).
  Article CAS PubMed Google Scholar
• Sun, J., Cecic, I., Parkins, C. S. & Korbelik, M. Neutrophils as inflammatory and immune effectors in photodynamic therapy-treated mouse SCCVII tumours. Photochem. Photobiol. Sci. 1, 690–695 (2002).
  Article CAS PubMed Google Scholar
• Cecic, I. & Korbelik, M. Mediators of peripheral blood neutrophilia induced by photodynamic therapy of solid tumors. Cancer Lett. 183, 43–51 (2002).
  Article CAS PubMed Google Scholar
• Canti, G. et al. Antitumor immunity induced by photodynamic therapy with aluminum disulfonated phthalocyanines and laser light. Anti-Cancer Drugs 5, 443–447 (1994).
  Article CAS PubMed Google Scholar
• Korbelik, M., Krosl, G., Krosl, J. & Dougherty, G. J. The role of host lymphoid populations in the response of mouse EMT6 tumor to photodynamic therapy. Cancer Res. 56, 5647–5652 (1996). One of the first reports to show T-cell mediated immune response against cancer after PDT.
  CAS PubMed Google Scholar
• Korbelik, M. & Dougherty, G. J. Photodynamic therapy-mediated immune response against subcutaneous mouse tumors. Cancer Res. 59, 1941–1946 (1999).
  CAS PubMed Google Scholar
• Hendrzak-Henion, J. A. et al. Role of the immune system in mediating the antitumor effect of benzophenothiazine photodynamic therapy. Photochem. Photobiol. 69, 575–581 (1999).
  Article CAS PubMed Google Scholar
• Castano, A. P., Liu, Q. & Hamblin, M.R. A green fluorescent protein-expressing murine tumour but not its wild-type counterpart is cured by photodynamic therapy. Br. J. Cancer 94, 391–397 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Uenaka, A. & Nakayama, E. Murine leukemia RL male 1 and sarcoma Meth A antigens recognized by cytotoxic T lymphocytes (CTL). Cancer Sci. 94, 931–936 (2003).
  Article CAS PubMed Google Scholar
• Gollnick, S. O., Vaughan, L. & Henderson, B. W. Generation of effective antitumor vaccines using photodynamic therapy. Cancer Res. 62, 1604–1608 (2002). Shows that PDT is especially effective in preparing vaccines from tumour cell lysates.
  CAS PubMed Google Scholar
• Korbelik, M. & Sun, J. Photodynamic therapy-generated vaccine for cancer therapy. Cancer Immunol. Immunother. 55, 900–909 (2005).
  Article CAS PubMed Google Scholar
• Takeda, K., Kaisho, T. & Akira, S. Toll-like receptors. Annu. Rev. Immunol. 21, 335–376 (2003).
  Article CAS PubMed Google Scholar
• Kadowaki, N. et al. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J. Exp. Med. 194, 863–869 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Krug, A. et al. Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12. Eur. J. Immunol. 31, 3026–3037 (2001).
  Article CAS PubMed Google Scholar
• Supajatura, V. et al. Protective roles of mast cells against enterobacterial infection are mediated by Toll-like receptor 4. J. Immunol. 167, 2250–2256 (2001).
  Article CAS PubMed Google Scholar
• Seya, T. et al. Role of toll-like receptors and their adaptors in adjuvant immunotherapy for cancer. Anticancer Res. 23, 4369–4376 (2003).
  CAS PubMed Google Scholar
• Myers, R. C. et al. Modulation of hematoporphyrin derivative-sensitized phototherapy with corynebacterium parvum in murine transitional cell carcinoma. Urology 33, 230–235 (1989).
  Article CAS PubMed Google Scholar
• Korbelik, M., Sun, J. & Posakony, J. J. Interaction between photodynamic therapy and BCG immunotherapy responsible for the reduced recurrence of treated mouse tumors. Photochem. Photobiol. 73, 403–409 (2001).
  Article CAS PubMed Google Scholar
• Korbelik, M. & Cecic, I. Enhancement of tumour response to photodynamic therapy by adjuvant mycobacterium cell-wall treatment. J. Photochem. Photobiol. B 44, 151–158 (1998).
  Article CAS PubMed Google Scholar
• Uehara, M. et al. Enhancement of the photodynamic antitumor effect by streptococcal preparation OK-432 in the mouse carcinoma. Cancer Immunol. Immunother. 49, 401–409 (2000).
  Article CAS PubMed Google Scholar
• Taylor, P. R. et al. The b-glucan receptor, dectin-1, is predominantly expressed on the surface of cells of the monocyte/macrophage and neutrophil lineages. J. Immunol. 169, 3876–3882 (2002).
  Article CAS PubMed Google Scholar
• Roeder, A. et al. Toll-like receptors as key mediators in innate antifungal immunity. Med. Mycol. 42, 485–498 (2004).
  Article CAS PubMed Google Scholar
• Krosl, G. & Korbelik, M. Potentiation of photodynamic therapy by immunotherapy: the effect of schizophyllan (SPG). Cancer Lett. 84, 43–49 (1994).
  Article CAS PubMed Google Scholar
• Chen, W. R. et al. Enhancement of laser cancer treatment by a chitosan-derived immunoadjuvant. Photochem. Photobiol. 81, 190–195 (2005).
  Article CAS PubMed Google Scholar
• Korbelik, M., Sun, J., Cecic, I. & Serrano, K. Adjuvant treatment for complement activation increases the effectiveness of photodynamic therapy of solid tumors. Photochem. Photobiol. Sci. 3, 812–816 (2004).
  Article CAS PubMed Google Scholar
• Korbelik, M., Naraparaju, V. R. & Yamamoto, N. Macrophage-directed immunotherapy as adjuvant to photodynamic therapy of cancer. Br. J. Cancer 75, 202–207 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Bellnier, D. A. Potentiation of photodynamic therapy in mice with recombinant human tumor necrosis factor-a. J. Photochem. Photobiol. B. 8, 203–210 (1991).
  Article CAS PubMed Google Scholar
• Golab, J. et al. Potentiation of the anti-tumour effects of Photofrin-based photodynamic therapy by localized treatment with G-CSF. Br. J. Cancer 82, 1485–1491 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Krosl, G., Korbelik, M., Krosl, J. & Dougherty, G. J. Potentiation of photodynamic therapy-elicited antitumor response by localized treatment with granulocyte-macrophage colony-stimulating factor. Cancer Res. 56, 3281–3286 (1996).
  CAS PubMed Google Scholar
• North, R. J. Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells. J. Exp. Med. 155, 1063–1074 (1982).
  Article CAS PubMed Google Scholar
• Zagozdzon, R. & Golab, J. Immunomodulation by anticancer chemotherapy: more is not always better (review). Int. J. Oncol. 18, 417–424 (2001).
  CAS PubMed Google Scholar
• Castano, A. P. & Hamblin, M. R. Anti-tumor immunity generated by photodynamic therapy in a metastatic murine tumor model. Proc. SPIE 5695, 7–16 (2005).
  Article CAS Google Scholar
• Fu, S. et al. TGF-β induces Foxp3 + T-regulatory cells from CD4 + CD25- precursors. Am. J. Transplant 4, 1614–1627 (2004).
  Article CAS PubMed Google Scholar
• Wahl, S. M., Swisher, J., McCartney-Francis, N. & Chen, W. TGF-β: the perpetrator of immune suppression by regulatory T cells and suicidal T cells. J. Leukoc. Biol. 76, 15–24 (2004).
  Article CAS PubMed Google Scholar
• Jalili, A. et al. Effective photoimmunotherapy of murine colon carcinoma induced by the combination of photodynamic therapy and dendritic cells. Clin. Cancer Res. 10, 4498–4508 (2004).
  Article CAS PubMed Google Scholar
• Saji, H. et al. Systemic antitumor effect of intratumoral injection of dendritic cells in combination with local photodynamic therapy. Clin. Cancer Res. 12, 2568–2574 (2006). The immune response produced by PDT and dendritic cells can regress a distant untreated tumour.
  Article CAS PubMed Google Scholar
• Korbelik, M. & Sun, J. Cancer treatment by photodynamic therapy combined with adoptive immunotherapy using genetically altered natural killer cell line. Int. J. Cancer 93, 269–274 (2001).
  Article CAS PubMed Google Scholar
• Hunt, D. W. & Levy, J. G. Immunomodulatory aspects of photodynamic therapy. Expert Opin. Investig. Drugs 7, 57–64 (1998).
  Article CAS PubMed Google Scholar
• Musser, D. A., Camacho, S. H., Manderscheid, P. A. & Oseroff, A. R. The anatomic site of photodynamic therapy is a determinant for immunosuppression in a murine model. Photochem. Photobiol. 69, 222–225 (1999).
  Article CAS PubMed Google Scholar
• Simkin, G. O., Tao, J. S., Levy, J. G. & Hunt, D. W. IL-10 contributes to the inhibition of contact hypersensitivity in mice treated with photodynamic therapy. J. Immunol. 164, 2457–2462 (2000). Describes PDT-induced immune suppression as evidenced by reduction of CHS.
  Article CAS PubMed Google Scholar
• Gollnick, S. O. et al. IL-10 does not play a role in cutaneous Photofrin photodynamic therapy- induced suppression of the contact hypersensitivity response. Photochem. Photobiol. 74, 811–816. (2001).
  Article CAS PubMed Google Scholar
• Musser, D. A. & Oseroff, A. R. Characteristics of the immunosuppression induced by cutaneous photodynamic therapy: persistence, antigen specificity and cell type involved. Photochem. Photobiol. 73, 518–524 (2001).
  Article CAS PubMed Google Scholar
• Ohtani, M., Kobayashi, Y. & Watanabe, N. Gene expression in the elicitation phase of guinea pig DTH and CHS reactions. Cytokine 25, 246–253 (2004).
  Article CAS PubMed Google Scholar
• Lou, P. J. et al. Interstitial photodynamic therapy as salvage treatment for recurrent head and neck cancer. Br. J. Cancer 91, 441–446 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Abdel-Hady, E. S. et al. Immunological and viral factors associated with the response of vulval intraepithelial neoplasia to photodynamic therapy. Cancer Res. 61, 192–196. (2001). One of the few papers describing immune response after PDT in humans.
  CAS PubMed Google Scholar
• Shikowitz, M. J. et al. Clinical trial of photodynamic therapy with meso-tetra (hydroxyphenyl) chlorin for respiratory papillomatosis. Arch. Otolaryngol. Head Neck Surg. 131, 99–105 (2005).
  Article PubMed Google Scholar
• Pasare, C. & Medzhitov, R. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 299, 1033–1036 (2003).
  Article CAS PubMed Google Scholar